Last updated date
ABOUT THIS STUDY
A six week, fixed dose, double-blind, double-dummy, placebo, and active controlled, multicentre trial to evaluate the safety and efficacy of CP-316,311 in outpatients with major depressive disorder.
Pfizer Investigational Site
Bellevue, Washington, , United States
Major Depressive Disorder
Females and Males
18 + years
- Outpatients with DSM-IV major depressive disorder
- Women of child bearing potential
Interested in learning more about clinical trials?
Discover how clinical trials work and the impact your participation could have.
TRY A NEW SEARCH
Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Based on your search, you may also be interested in
Major Depressive DisorderSertraline vs. Venlafaxine XR
- Nashville, Tennessee
Major Depressive DisorderBrain Imaging Techniques That Predict Antidepressant Responsiveness
- Madison, Wisconsin
Major Depressive DisorderA Study of MD-120 in Patients With Depression
Major Depressive DisorderNeurocognition and Work Productivity in Major Depressive Disorder (MDD)
- Vancouver, British Columbia